Wearable monitors and a phone program for recovery after lung cancer surgery
Tests a wearable monitor with a rehabilitation program after non-small cell lung cancer surgery.
Key facts
- Who runs it
- West China Hospital
- Where
- Chengdu, ChinaSee the site
- Trial code
- Registry title
- Rehabilitation With Wearable Monitors for Post-Lung Cancer Surgery
- Status
- Not yet recruiting
- People taking part
- 126 people, planned
- Started
- 31 Aug 2026
- Expected to end
- 31 Aug 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Wireless Wearable Vital Sign and Activity Monitor
- Digital Postoperative Rehabilitation Program
- Standard Postoperative Rehabilitation Education
- Record updated
- 2 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with non-small cell lung cancer who have had planned surgery to remove part of the lung, and who can recover at home.
- Age
- 18 to 85 years
- Sex
- All sexes can join.
- Disease stage
- Confirmed primary non-small cell lung cancer, treated with lobectomy or segmentectomy (planned surgery meant to remove all of the cancer).
- Earlier treatment
- Must have had planned lobectomy or segmentectomy surgery, with discharge planned between day 2 and day 7 after the operation.
Main reasons for not taking part
- Long-term home oxygen therapy, or severe breathing problems at rest
- Severe, uncontrolled heart or blood vessel disease, severe liver failure, or severe kidney failure
- Other conditions that clearly affect movement or the ability to follow the trial
- Known or suspected allergy to medical adhesives or wearable device materials
- Cannot use a smartphone app and wearable devices, even with a caregiver's help
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Age ≥18 and ≤85 years
- Histopathologically confirmed primary non-small cell lung cancer (NSCLC) who have undergone elective curative-intent lobectomy or segmentectomy
- Planned discharge between postoperative day 2 and day 7, and judged by the investigator to be clinically stable and suitable for home-based rehabilitation
- Able to operate a smartphone application and wearable devices independently or with caregiver assistance
- Willing and able to provide written informed consent
Who cannot take part
- Pre-existing long-term home oxygen therapy, or severe resting respiratory dysfunction
- Concurrent severe, uncontrolled cardiovascular disease, severe hepatic insufficiency, or severe renal insufficiency
- Other diseases or conditions that significantly affect motor function or compliance
- Known or suspected contact allergy to medical adhesives or materials used in the wearable devices
- Any other condition that, in the investigator's judgment, makes the subject unsuitable for participation
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Where in China
- West China HospitalChengdu, ChinaContact: Xuelei maNo longer taking part
About the trial
What the trial wants to find out
This is a prospective, open-label, parallel-group, 1:1 randomized controlled trial evaluating whether a wireless wearable mobile monitoring device combined with a digital rehabilitation program improves pulmonary function at 90 days postoperatively in patients undergoing curative-intent lobectomy or segmentectomy for non-small cell lung cancer (NSCLC).
Read full original descriptionShow less
Eligible participants will be randomized to either the intervention group or the control group. Both groups receive standard postoperative rehabilitation education. The intervention group additionally receives a wearable device (chest patch or wristband) for continuous monitoring of SpO₂, heart rate, respiratory rate, and physical activity, along with a smartphone-based digital rehabilitation program including individualized exercise prescriptions (aerobic, resistance, and inspiratory muscle training), daily symptom diaries, and remote feedback with threshold-triggered alerts for up to 90 days after discharge. The control group receives standard rehabilitation education with routine follow-up.
The primary endpoint is the between-group difference in FEV1% predicted at postoperative day 90, analyzed using ANCOVA adjusted for baseline FEV1% predicted. Secondary endpoints include FVC% predicted, 6-minute walk distance, daily step count, SpO₂ <90% time burden, quality of life (EORTC QLQ-C30/LC13, mMRC), 90-day readmission and emergency visit rates, and safety outcomes.
A total of 126 participants (63 per group) will be enrolled. The study is being conducted at West China Hospital of Sichuan University from June 2026 to October 2027.
The 2 groups in the trial
- Digital Rehabilitation with Wearable MonitoringTreatment being tested
Participants receive standard postoperative rehabilitation education plus a wireless wearable mobile monitoring and digital rehabilitation program for 90 days post-discharge. This includes: (1) continuous vital sign and activity monitoring via a wearable chest patch or wristband (SpO₂, heart rate, respiratory rate, physical activity); (2) individualized digital rehabilitation prescriptions (aerobic, resistance, and inspiratory muscle training) with daily symptom diaries; and (3) remote feedback with threshold-triggered graded responses.
Treatment: Wireless Wearable Vital Sign and Activity Monitor and Digital Postoperative Rehabilitation Program
- Standard Postoperative RehabilitationExisting treatment, for comparison
Participants receive standard postoperative rehabilitation education, including breathing exercises (abdominal breathing, pursed-lip breathing, effective coughing), progressive walking recommendations, and routine follow-up visits at 1 month and 3 months. No wearable monitoring or digital rehabilitation prescription is provided.
Treatment: Standard Postoperative Rehabilitation Education
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Clinical Trial of Postoperative Rehabilitation for Non-Small Cell Lung Cancer Based on Wireless Wearable Mobile Monitoring Devices
- Plain-language title
- Wearable monitors and a phone program for recovery after lung cancer surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07733492, who can take part
- Record updated
- 2 September 2026